Litcius/Paper detail

Cardiac radiation dose is associated with inferior survival but not cardiac events in patients with locally advanced non-small cell lung cancer in the era of immune checkpoint inhibitor consolidation

Nikhil Yegya‐Raman, Sang Ho Lee, Cole Friedes, Xingmei Wang, Michelle Iocolano, Timothy P. Kegelman, Lian Duan, Bolin Li, Eva Berlin, Kristine Kim, Abigail Doucette, Srinivas Denduluri, William P. Levin, Keith A. Cengel, Roger B. Cohen, Corey J. Langer, Boon‐Keng Teo, Wei Zou, Rupal P. O'Quinn, Joseph O. Deasy, Jeffrey D. Bradley, Lova Sun, Bonnie Ky, Ying Xiao, Steven J. Feigenberg

2023Radiotherapy and Oncology24 citationsDOIOpen Access PDF

Topics & Concepts

MedicineInternal medicineMaceCardiologyClinical endpointCumulative incidenceHeart failureLung cancerCoronary artery diseaseMyocardial infarctionTransplantationPercutaneous coronary interventionRandomized controlled trialCancer Immunotherapy and BiomarkersLung Cancer Diagnosis and TreatmentChemotherapy-induced cardiotoxicity and mitigation
Cardiac radiation dose is associated with inferior survival but not cardiac events in patients with locally advanced non-small cell lung cancer in the era of immune checkpoint inhibitor consolidation | Litcius